Guillermo Aldave Orzaiz, MD, PhD
- Texas Medical Center
Director, Neurosurgery Oncology
Texas Children's Hospital
Assistant Professor, Pediatric Neurosurgery, Baylor College of Medicine
|Univ of Navarra||medical school||Doctor of Medicine||2008|
|Clinica Univ de Navarra||residency||Neurosurgery||2013|
|Clinica Univ de Navarra||fellowship||Neurosurgery||2014|
Clinical & Research Interests:
Dr. Aldave’s clinical interests include maximizing the safe treatment of pediatric brain tumors and how to improve patients’ clinical outcomes and quality of life. His research interests include the use of oncolytic virus in the treatment of high grade pediatric brain tumors, and the development new and unique strategies of treatment for tumor patients, such as the use of 5 aminolevulinic acid for the resection of high grade gliomas.
Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, Díez-Valle R. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-ALA guided surgery. Neurosurgery 2013 Jun;72(6):915-20.
Tejada S, Aldave G, Marigil M, Gallego J, Dominguez PD, Díez-Valle R. Factors associated with a higher rate of distant failure after primary treatment for glioblastoma. J Neurooncol Oct 2013.
Aldave G, Hansen D, Luerssen T, Jea A. Assessing Resident Operative Skills for Shunt Surgery in Pediatric Neurosurgery. Journal of Neurosurgery: Pediatrics April. 2016.
Aldave G, Hansen D, Hwang S, Moreno A, Briceno V, Jea A "Spinal Column Shortening for Tethered Cord Syndrome Associated with Myelomeningocele, Lumbosacral Lipoma, and Lipomyelomeningocele in Children and Young Adults. Journal of Neurosurgery: Pediatrics June. 2016.